• SGI-1027 and Everolimus in Renal Cancer

  2026-08-16

  A 2024 Advanced Science study identifies the DNMT1 inhibitor SGI-1027 as a methuosis inducer that cooperates with everolimus in renal cancer models. The combination links lysosomal membrane permeability to apoptosis and GSDME-dependent pyroptosis, offering a mechanistic strategy for addressing everolimus resistance.

• Anti Reverse Cap Analog for mRNA Translation

  2026-08-15

  Anti Reverse Cap Analog (ARCA) streamlines orientation-specific mRNA capping for higher translation in reporter, nanoparticle, and therapeutic-expression workflows. This practical guide connects cap chemistry with the targeted mRNA nanoparticle strategy reported in ischemic stroke research, while emphasizing assay controls, storage, and troubleshooting.

• AMC-Hem Reveals New Regulation of HO-1

  2026-08-14

  The reference study introduces AMC-Hem, an improved red-shifted aminocoumarin fluorescence probe that enables real-time measurement and imaging of heme oxygenase-1 activity in live human macrophages. Its application links HO-1 activity to lysosomal structures, identifies non-transcriptional regulatory effects, and extends activity measurement to human serum.

• PreScission Protease (PSP): Practical Tag Cleavage

  2026-08-14

  PreScission Protease (PSP), SKU K1101, is an HRV 3C protease fusion enzyme for removing compatible affinity tags from recombinant proteins at low temperature. It is intended for site-specific fusion protein tag cleavage in purified samples, not for nonspecific proteolysis or workflows that lack the required recognition sequence.

• Alfuzosin HCl–Tadalafil: Green UV Analysis

  2026-08-13

  Alqahtani and colleagues developed the first reported spectrophotometric procedures for resolving the strongly overlapping absorbance spectra of Alfuzosin HCl and tadalafil in fixed-dose tablets. Their absorbance subtraction and ratio difference strategies provide a comparatively simple, affordable route for simultaneous quality analysis without relying on chromatographic instrumentation.

• AG-126 for ERK Signaling and Neuroinflammation

  2026-08-13

  AG-126 (Tyrphostin AG-126) offers a practical way to perturb ERK1/2 phosphorylation in cell-based, inflammatory, and exploratory neurobiology workflows. Its strongest use-case is mechanistic dissection: pair acute phospho-ERK measurements with cytokine, excitability, or behavioral-model readouts rather than treating it as a validated ASD therapy.

• AmpliFold Capture-and-Release for LFA Sensitivity

  2026-08-12

  The ChemRxiv preprint presents AmpliFold, a capture-and-release architecture that temporarily sequesters antigen-bound complexes before high-affinity rebinding in a lateral flow assay. In a HER2 model, linker and capture-geometry optimization improved signal distribution and produced substantial sensitivity gains without relying solely on faster antibody association kinetics.

• PreScission Protease (PSP): Tag Cleavage Guide

  2026-08-12

  PreScission Protease (PSP) enables sequence-directed removal of affinity tags from recombinant fusion proteins through HRV 3C protease cleavage at a defined site. It is suited to low-temperature purification workflows when the cleavage sequence is present and accessible, but should not be used without validation for constructs lacking the site or buffers incompatible with the enzyme.

• Cy3 TSA Fluorescence System Kit for Astrocyte Mapping

  2026-08-11

  Translate astrocyte atlas discoveries into spatially resolved protein, RNA, and morphology assays with a sensitive Cy3 TSA workflow. This TSA fluorescence kit is especially useful when conventional fluorescence microscopy detection cannot reliably reveal low-abundance targets in fixed brain tissue or cells.

• Br-DAPI in Diabetic Cardiomyopathy DNA Assays

  2026-08-11

  Br-DAPI is a DAPI fluorescent dye for selective DNA labeling in live and fixed cells. This article explains how its staining chemistry can strengthen diabetic cardiomyopathy assays while clarifying what DNA fluorescence can—and cannot—prove about lipotoxicity, ER stress, and apoptosis.

• Anti Reverse Cap Analog for mRNA Workflows

  2026-08-10

  Learn how Anti Reverse Cap Analog (ARCA) improves orientation-controlled synthetic mRNA capping for reporter assays, LNP delivery, gene editing, and reprogramming research. A practical workflow connects cap chemistry with the targeted mRNA nanoparticle strategy reported in ACS Nano while separating demonstrated findings from optimization hypotheses.

• Tubastatin A in Porcine Post-Resuscitation Injury

  2026-08-09

  A porcine cardiac arrest study found that Tubastatin A reduced post-resuscitation myocardial dysfunction, cardiac injury biomarkers, and tissue signals associated with GSDME-mediated pyroptosis and MLKL-mediated necroptosis. The work supports a mechanistic link between HDAC6 inhibition and myocardial ischemia–reperfusion protection, while its small, short-term design limits clinical and causal interpretation.

• Ginkgo Cocktail Enhances Yeast Mitochondrial Longevity

  2026-08-08

  The reference study combines LC-MS/MS profiling, network pharmacology, and yeast aging assays to identify a four-compound Ginkgo biloba cocktail that improves mitochondrial function and extends chronological lifespan. Its main practical contribution is a data-guided strategy for testing combinations of natural products rather than assuming that activity from a crude extract is attributable to one dominant molecule.

• X-Gal as a Decision Tool in Molecular Cloning

  2026-08-07

  X-Gal turns β-galactosidase activity into a visible molecular cloning decision, but its greatest value depends on interpreting color as evidence rather than proof. This article connects blue-white colony screening with activity-dependent biology and shows how to design more discriminating, reproducible assays.

• Self-Assembling Virus-Mimicking Particles for Extrahepatic m

  2026-08-07

  This article examines a recent innovation in mRNA therapeutics: the self-assembling enveloped virus-mimicking particle (EVMP) platform. By enabling precise and efficient delivery of mRNA to extrahepatic tissues, this technology addresses longstanding challenges in mRNA-based immunotherapy and gene modulation, with notable implications for cytokine mRNA applications.

8016 records 3/535 page Previous Next 12345 下5页 Last page